Abstract:Background: MicroRNAs (miRNAs) regulate osteogenic differentiation processes and influence the development of osteoporosis (OP). This study aimed to investigate the potential role of miR-466 l-3p in OP. Methods: The expression levels of miR-466 l-3p and fibroblast growth factor 23 (FGF23) were quantified in the trabeculae of the femoral neck of 40 individuals with or without OP using quantitative reverse transcription-polymerase chain reaction (qRT-PCR). The impact of miR-466 l-3p or FGF23 expression on cell proliferation and the expression levels of runt-related transcription factor 2 (RUNX2), type I collagen (Col1), osteocalcin (OCN), osterix (OSX) and dentin matrix protein 1 (DMP1) was quantified in human bone marrow mesenchymal stem cells (hBMSCs) overexpressing miR-466 l-3p. Furthermore, alkaline phosphatase (ALP) staining and alizarin red staining were performed to measure ALP activity and the levels of calcium deposition, respectively. In addition, bioinformatics analysis, luciferase reporter assays, and RNA pull-down assays were conducted to explore the molecular mechanisms underlying the effects of miR-466 l-3p and FGF23 in osteogenic differentiation of hBMSCs. Results: The expression levels of miR-466 l-3p were significantly lower in femoral neck trabeculae of patients with OP than in the control cohort, whereas FGF23 levels exhibited the opposite trend. Furthermore, miR-466 l-3p levels were upregulated and FGF23 levels were downregulated in hBMSCs during osteogenic differentiation. Moreover, the high miR-466 l-3p expression enhanced the mRNA expression of RUNX2, Col1, OCN, OSX and DMP1, as well as cell proliferation, ALP activity, and calcium deposition in hBMSCs. FGF23 was found to be a direct target of miR-466 l-3p. FGF23 overexpression downregulated the expression of osteoblast markers and inhibited the osteogenic differentiation induced by miR-466 l-3p overexpression. qRT-PCR and Western blot assays showed that miR-466 l-3p overexpression decreased the expression levels of mRNAs and proteins associated with the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling pathway, whereas FGF23 upregulation exhibited the opposite trend. Conclusion: In conclusion, these findings suggest that miR-466 l-3p enhances the osteogenic differentiation of hBMSCs by suppressing FGF23 expression, ultimately preventing OP.

Fgf18 Inhibits Mc3t3-E1 Cell Osteogenic Differentiation Via the Erk Signaling Pathway

Mechano-Growth Factor E Peptide Inhibits the Differentiation and Mineralization of Osteoblasts

Fibroblast growth factor 23 inhibits osteogenic differentiation and mineralization of chicken bone marrow mesenchymal stem cells

FGF18 Inhibits Clear Cell Renal Cell Carcinoma Proliferation and Invasion Via Regulating Epithelial-Mesenchymal Transition.

FGF2 positively regulates osteoclastogenesis via activating the ERK-CREB pathway

A novel miR-466l-3p/FGF23 axis promotes osteogenic differentiation of human bone marrow mesenchymal stem cells

TRIB3 Inhibits Proliferation and Promotes Osteogenesis in Hbmscs by Regulating the ERK1/2 Signaling Pathway.

Effect of Fibroblast Growth Factor Receptor 2 on Osteogenic Differentiation of Mouse Bone Marrow Mesenchymal Stem Cells

Fibroblast Growth Factor 18 Exerts Anti-Osteoarthritic Effects Through PI3K-AKT Signaling and Mitochondrial Fusion and Fission.

Estrogen Represses Tgfbr1 and Bmpr1a Expression Via Estrogen Receptor Beta in MC3T3-E1 Cells

FGF18 Enhances Migration and the Epithelial-Mesenchymal Transition in Breast Cancer by Regulating Akt/GSK3β/Β-Catenin Signaling

Fibroblast growth factor 23 (FGF23) and alpha-klotho stimulate osteoblastic MC3T3.E1 cell proliferation and inhibit mineralization

Fgf18 Enhances Migration And The Epithelial-Mesenchymal Transition In Breast Cancer By Regulating Akt/Gsk3 Beta/B-Catenin Signaling

Lactoferrin Promotes MC3T3-E1 Osteoblast Cells Proliferation Via MAPK Signaling Pathways.

The Effects of MGF and E Peptide on the Differentiation of Osteoblasts*

Secreted klotho protein attenuates osteogenic differentiation of human bone marrow mesenchymal stem cells in vitro via inactivation of the FGFR1/ERK signaling pathway.

Effect of recombinant human fibroblast growth factor 21 on the mineralization of cementoblasts and its related mechanism

CMTM3 Suppresses Bone Formation and Osteogenic Differentiation of Mesenchymal Stem Cells Through Inhibiting Erk1/2 and RUNX2 Pathways

Egfr Signaling Suppresses Osteoblast Differentiation and Inhibits Expression of Master Osteoblastic Transcription Factors Runx2 and Osterix

Effect of Fibroblast Growth Factor 9 on the Osteogenic Differentiation of Bone Marrow Stromal Stem Cells and Dental Pulp Stem Cells

Fibroblast growth factor signalling regulates the development of tooth root